Abciximab: A Pharmacoeconomic Review of its Use in Percutaneous Coronary Revascularisation

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.16, Iss.6, 1999-12, pp. : 711-741

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Abciximab: An Updated Review of its Therapeutic Use in Patients with Ischaemic Heart Disease Undergoing Percutaneous Coronary Revascularisation

By Ibbotson T. McGavin J.K. Goa K.L.

Drugs, Vol. 63, Iss. 11, 2003-01 ,pp. : 1121-1163

Adis International

Access to resources Recommend Favorite

Eptifibatide: A Pharmacoeconomic Review of its Use in Percutaneous Coronary Intervention and Acute Coronary Syndromes

By Plosker G.L. Ibbotson T.

PharmacoEconomics, Vol. 21, Iss. 12, 2003-01 ,pp. : 885-912

Adis International

Access to resources Recommend Favorite

Bivalirudin: A Review of its Use in Patients Undergoing Percutaneous Coronary Intervention

By Moen Marit D. Keating Gillian M. Wellington Keri

Drugs, Vol. 65, Iss. 13, 2005-01 ,pp. : 1869-1891

Adis International

Access to resources Recommend Favorite

Fondaparinux: A Pharmacoeconomic Review of its Use in the Management of Non-ST-Segment Elevation Acute Coronary Syndrome

By McKeage Kate Lyseng-Williamson Katherine A.

PharmacoEconomics, Vol. 28, Iss. 8, 2010-08 ,pp. : 687-698

Adis International

Access to resources Recommend Favorite

Pravastatin: A Pharmacoeconomic Review of its use in Primary and Secondary Prevention of Coronary Heart Disease

By Coukell A.J. Wilde M.I.

PharmacoEconomics, Vol. 14, Iss. 2, 1998-08 ,pp. : 217-236

Adis International

Access to resources Recommend Favorite